Aperçu: G.M.
La
suppression 16q24 impliquant le gène ANKRD11, allant de 137 kb à 2 Mb, a
été associée à un syndrome de microdélétion caractérisé par une
déficience cognitive variable, un trouble du spectre de l'autisme, des
dysmorphies faciales avec des anomalies dentaires, des anomalies
cérébrales affectant essentiellement le corps calleux et une faible taille.
Eur J Hum Genet. 2017 Apr 19. doi: 10.1038/ejhg.2017.49.
Haploinsufficiency for ANKRD11-flanking genes makes the difference between KBG and 16q24.3 microdeletion syndromes: 12 new cases
Novara F1, Rinaldi B1, Sisodiya SM2,3, Coppola A4, Giglio S5,6, Stanzial F7, Benedicenti F7, Donaldson A8, Andrieux J9, Stapleton R10, Weber A11, Reho P1, van Ravenswaaij-Arts C12, Kerstjens-Frederikse WS12, Vermeesch JR13, Devriendt K13, Bacino CA14,15, Delahaye A16,17,18, Maas SM19,20, Iolascon A21,22, Zuffardi O1.
Author information
- 1
- Department of Molecular Medicine, University of Pavia, Pavia, Italy.
- 2
- Department of Clinical and Experimental Epilepsy, NIHR University College London Hospitals Biomedical Research Centre, UCL Institute of Neurology, London, UK.
- 3
- The Epilepsy Society, Chalfont-St-Peter, Bucks, UK.
- 4
- Epilepsy Centre, Department of Neuroscience, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.
- 5
- Medical Genetics Unit, Department of Clinical and Experimental Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy.
- 6
- Department of Biomedical Experimental and Clinical Sciences 'Mario Serio', Medical Genetics Unit, Meyer Children's University Hospital, Florence, Italy.
- 7
- Servizio di Consulenza Genetica, Centro Provinciale di Coordinamento della Rete delle Malattie Rare, Azienda Sanitaria dell'Alto-Adige, Bolzano, Italy.
- 8
- Department of Clinical Genetics, St Michael's Hospital, Bristol, UK.
- 9
- Institut de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU de Lille, France.
- 10
- Genetic Health Service NZ-Northern Hub, Building 30 Auckland City Hospital, Auckland, New Zealand.
- 11
- Merseyside and Cheshire Clinical Genetics Service, Liverpool Women's (NHS) Foundation Hospital Trust, Liverpool, UK.
- 12
- Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- 13
- Laboratory of Cytogenetics and Genome Research, Center of Human Genetics, KU Leuven, Leuven, Belgium.
- 14
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
- 15
- Texas Children's Hospital, Houston, TX, USA.
- 16
- INSERM, UMR 1141, Robert Debré University Hospital, Paris, France.
- 17
- Cytogenetics Unit, AP-HP, Jean Verdier Hospital, Bondy, France.
- 18
- Paris 13 University, Sorbonne Paris Cité, UFR SMBH, Bobigny, France.
- 19
- Department of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands.
- 20
- Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
- 21
- Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.
- 22
- CEINGE Biotecnologie Avanzate Scarl, Naples, Italy.
Abstract
16q24
deletion involving the ANKRD11 gene, ranging from 137 kb to 2 Mb, have
been associated with a microdeletion syndrome characterized by variable
cognitive impairment, autism spectrum disorder,
facial dysmorphisms with dental anomalies, brain abnormalities
essentially affecting the corpus callosum and short stature. On the
other hand, patients carrying either deletions encompassing solely
ANKRD11 or its loss-of-function variants were reported in association
with the KBG syndrome, characterized by a very similar phenotype,
including mild-to-moderate intellectual disability, short stature and
macrodontia of upper incisors, with inter and intrafamilial variability.
To assess whether the haploinsufficiency of ANKRD11-flanking genes,
such as ZFPM1, CDH15 and ZNF778, contributed to either the severity of
the neurological impairment or was associated with other clinical
features, we collected 12 new cases with a 16q24.2q24.3 deletion (de
novo in 11 cases), ranging from 343 kb to 2.3 Mb. In 11 of them, the
deletion involved the ANKRD11 gene, whereas in 1 case only flanking
genes upstream to it were deleted. By comparing the clinical and genetic
features of our patients with those previously reported, we show that
the severity of the neurological phenotype and the frequency of
congenital heart defects characterize the deletions that, besides
ANKRD11, contain ZFPM1, CDH15 and ZNF778 as well. Moreover, the presence
of thrombocytopenia and astigmatism should be taken into account to
distinguish between 16q24 microdeletion syndrome and KBG syndrome. The
single patient not deleted for ANKRD11, whose phenotype is characterized
by milder psychomotor delay, cardiac congenital malformation,
thrombocytopenia and astigmatism, confirms all this data.European
Journal of Human Genetics advance online publication, 19 April 2017;
doi:10.1038/ejhg.2017.49.
- PMID: 28422132
- DOI: 10.1038/ejhg.2017.49
